Keurig plans to purchase Dr Pepper Snapple Group for USD 18.7 billion
Category: #world  By Dhananjay Punekar  Date: 2018-01-31
  • share
  • Twitter
  • Google Plus
  • Facebook
  • LinkedIn

Keurig plans to purchase Dr Pepper Snapple Group for USD 18.7 billion

JAB Holding Company, an investment firm that funds the coffee business of Keurig Green Mountain Inc. has decided to acquire Dr Pepper Snapple Group Inc. for USD 18.7 billion. JAB’s move to take over the soft drink business of Pepper as a part of its new plan for rapidly expanding across the emerging food & beverages sector has been deemed to be quite lucrative, as per analysts.

As a part of the purchase agreement, Dr Pepper’s stockholders are likely to receive USD 103.75 per share in the form of the special cash dividend.  Dr Pepper will also retain 13% of the ownership in the joint venture referred as Keurig Dr Pepper, while Keurig Green Mountain will acquire 87% of the ownership.

The prospective deal will apparently place JAB in direct competition with giant soft drink manufacturers such as PepsiCo Inc., Coca-Cola, 7 Up, Mott Apple Juice, and A&W Root Beer. Keurig Dr Pepper, the combined business entity, is anticipated to generate a yearly revenue of nearly USD 11 billion in the years ahead. With Dr Pepper manufacturing fast-emerging beverages such as Bai Brands and consumers increasing their preference for new soft drinks, the combined firm has been forecast can derive substantial revenue in the ensuing years.

Reports claim that Keurig contributed nearly 7.4 % towards U.S. coffee industry share last year, while Dr Pepper captured approximately 8.5% of the soft drinks market share during the same span. With the acquisition pact between the two reputed firms expected to be finalized in the next quarter of 2018, it is likely that the joint business unit will witness a significant rise in its market share.

Sources state that the deal is currently awaiting the approval from Dr Pepper’s investors as well as regulatory authorities.



About Author

Dhananjay Punekar

Email: dhananjay.p@news.marketsizeforecasters.com   

Dhananjay Punekar

Dhananjay Punekar presently develops content for a slew of portals, including Market Size Forecasters and Algosonline. A post graduate in mathematics and business administration, he worked in Infosys BPO Limited prior to switching his professional genre. As a content wr...

Read More

More News By Dhananjay Punekar

AstraZeneca gets import & marketing approval for Durvalumab in India
AstraZeneca gets import & marketing approval for Durvalumab in India
By Dhananjay Punekar

AstraZeneca Pharma India, a division of pharma & biopharma giant AstraZeneca plc, has received a green signal from the Indian drug regulating agency DCGI (Drug Controller General of India) for its drug Durvalumab c...

BP exits deal with Woolworths, retail firm looks out for alternatives
BP exits deal with Woolworths, retail firm looks out for alternatives
By Dhananjay Punekar

BP Plc, a UK based oil & gas firm, has decided to terminate its USD 1.8 billion acquisition deal with Australian retail giant Woolworths. For the record, the British oil & gas company had signed a pact to purch...

Sarepta obtains positive results on DMD therapy, shares skyrocket 50%
Sarepta obtains positive results on DMD therapy, shares skyrocket 50%
By Dhananjay Punekar

The shares of Sarepta Therapeutics Inc., a medical research & drug development firm, climbed up by 50% after the firm released initial results derived from clinical treatment on patients suffering from Duchenne mus...